IFAPP Academy partners with MAPS (Medical Affairs Professional Society)

IFAPP Academy and MAPS partner for medical affairs education and online cpd
From left to right: Kirk Shepard, MAPS Director; Travis Hege, MAPS CEO; Gustavo Kesselring, IFAPP Past President & IFAPP Academy Vice President; and Danie du Plessis, MAPS EMEA President

The IFAPP Academy is dedicated to providing high-quality education for medical affairs professionals. To achieve this goal, we have partnerships with two well known and highly respected academic institutions, King’s College London and Tufts CSDD in Boston. However, in effort to continue expanding our impact and support of the various functions in medical affairs, we have joined forces with MAPS for some exciting new initiatives.

MAPS and IFAPP Academy have signed a mutual agreement to facilitate the coordination and implementation of joint projects for the benefit of biomedical professionals in the development, testing, and monitoring of medicinal products. These undertakings will empower biomedical professionals to leverage their roles in the research, development, and commercialization activities conducted by the global biopharmaceutical industry. Initiatives will be developed to foster ethical conduct and the maintenance of professional autonomy to protect the safety and dignity of patients and research subjects.

Dr. Honorio Silva, IFAPP Academy President

“At the IFAPP Academy, we are enthused with the potential for this synergistic collaboration. This cooperative effort will allow biomedical professionals, serving in Medical Affairs related functions, better access to online, state of the art, competency-based education for professional development,” said Honorio Silva, MD, IFAPP Past President & IFAPP Academy Chief Executive Officer. “This opportunity could result in leveraged competence and improved performance in their functions for the benefit of patients, the sponsoring institutions, and society at large.”

Honorio Silva, MD, IFAPP Past President & IFAPP Academy Chief Executive Officer

MAPS and IFAPP Academy will cooperate in other areas of mutual interest, in particular, those concerning education and competency building in Medical Affairs. Soon both organizations will be able to work together on projects related to the capacitation of the various functions related to Medical Affairs within the biopharmaceutical and device industry and ensure that better medicines are available worldwide.

Travis Hege, MAPS CEO

“This collaboration partners two global non-profit organizations with similar visions, experienced leadership, and proven track records of promoting excellence and fostering capability building for the Medical Affairs function. MAPS is excited to work with IFAPP Academy in the production and delivery of the highest quality competency-building offerings for our members and the Medical Affairs Community at large.”

Travis Hege, MAPS CEO

About the Medical Affairs Professional Society

MAPS (https://www.medicalaffairs.org) is a global non-profit [501(c)(3)] organization of Medical Affairs professionals with nearly 2,000 individual members from over 160 life sciences companies, as well as those who provide valuable support to Medical Affairs organizations. Its mission is to advance the Medical Affairs profession and increase its impact across the life sciences industry by:

  1. Promoting excellence across Medical Affairs functions
  2. Developing guidelines to support industry standards and best practices
  3. Fostering advocacy for the Medical Affairs position
  4. Providing education and encouraging professional collaborations that support the practice of Medical Affairs

About IFAPP Academy

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy (https://ifappacademy.org/) is a non-profit organization based in the USA and affiliated with IFAPP. The Academy is a unique partnership between academia, industry, and professional associations to foster competencies and improve performance in medical affairs and medicines development. The IFAPP Academy-Kings College London, Medical Affairs in Medicines Development, Certification Program was created to achieve this goal. The online Program aims to provide the core cognitive competencies for effective performance in medicines development and medical affairs. The certification program is of particular value for those individuals already working in (or interested in joining) pharmaceuticals, academia, and regulatory agencies. Students completing the course receive a Certificate granted by King’s College London and IFAPP Academy, a Professional Certification issued by IFAPP and the IFAPP Academy, and the use of post-nominal letters (CMD) to attest certification.


Want to learn more about the IFAPP Academy – King’s College London, Medical Affairs in Medicines Development, Certification Program?

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy provides online Continuing Professional Development for Medical Affairs Professionals.

The IFAPP Academy is a non-profit organization whose mission is to promote, develop, and implement educational activities that support Pharmaceutical Medicine by enhancing the knowledge, expertise, and skills of pharmaceutical physicians and medicines development scientists worldwide. Partnered with King’s College London, the Academy offers Professional Certification for students successfully completing the course. Click here to learn more about the benefits of Professional Certification from the IFAPP Academy.

IFAPP & SIMeF present the 20th International Conference on Pharmaceutical Medicine (ICPM)

Save the date for the 20th International Conference on Pharmaceutical Medicine

IFAPP (the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine) and SIMeF (the Italian Association of Pharmaceutical Medicine) are proud to announce the forthcoming 20th ICPM (International Conference on Pharmaceutical Medicine). The Conference, Patients Centered Medicines Development: Facts and Expectations, will be jointly organized with the first SIMeF National Conference in March 2020 in Rome.

Mark your calendars for March 25 – 27, 2020 for the 20th ICPM and 1st National SIMeF

IFAPP President, Kyoko Imamura, MD, DrMedSci, PhD

“ICPM has been the important opportunity for us as professionals in pharmaceutical medicine, and we are delighted to develop it in Rome, where decades-long efforts have generated dedicated pharmaceutical physicians and medicines development scientists.”

IFAPP President Dr. Kyoko Imamura

20th ICPM: Patients Centered Medicines Development: Facts and Expectations

The International part of the Conference will cover the first two days, with 2 keynote speeches (CIOMS Secretary and Telethon Director), a round table of education in Pharmaceutical Medicine, 2 plenary sessions on the role of patients in drug development and the modern vision of Medical Affairs, and 8 parallel sessions during the two afternoons.

IFAPP President-elect, Marco Romano

“I have the privilege and the pleasure to host both the XX ICPM and the I SIMeF Conference in Rome: it is a unique opportunity for my country and especially for my Italian colleagues who may meet international speakers and collaborators.”

Dr. Marco Romano, SIMeF President, and IFAPP President-elect

1st National SIMeF Conference

The National part of the Conference will be held on the third day, March 27, and will have a morning session devoted to a round table on the status of clinical research in Italy. In the afternoon the General Assembly will take place, with the nomination of the new SIMeF President, and then a session devoted to Medical Devices.

See you in Rome, March 2020!

International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine

About the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP)

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) is a non-profit organization based in The Netherlands, whose mission is to promote Pharmaceutical Medicine by enhancing the knowledge, expertise and skills of pharmaceutical physicians and medicines development scientists world-wide.  The IFAPP Academy is a non-profit organization based in the USA affiliated with IFAPP and is responsible to run its educational activities.

Tufts CSDD Partners with IFAPP Academy to Develop an Innovative Online Course: “Leadership in Medical Affairs”

Tufts CSDD partners with IFAPP Academy to create online course, "Leadership in Medical Affairs."
Figure 1: From left to right: Robert Franco, Lead Facilitator; Honorio Silva, CEO of IFAPP Academy; Ken Kaitin, Director of Tufts CSDD; Ana B Salgado, IFAPP Academy Director of Strategic Operations; and Gustavo Kesselring IFAPP Academy VP

Tuesday, August 13th, 2019 — Tufts Center for the Study of Drug Development (Tufts CSDD) will partner with IFAPP Academy to create a new course, “Leadership in Medical Affairs”, that will be offered in 2020 as a complement to the IFAPP Academy-King’s College London-Tufts CSDD Professional Certification Program “Medical Affairs in Medicines Development.” The planning activities for this innovative approach to education and training, in this critical area for the medical role within the biopharmaceutical industry, have already started.  Dr. Kenneth Kaitin, Professor of Medicine and Director of Tufts CSDD and Dr. Ana Salgado, IFAPP Academy Director of Strategic Operations will coordinate the initiative.  Dr. Kaitin has also been appointed a member of the IFAPP Academy’s Advisory Council. 

The partnership with Tufts CSDD will provide IFAPP Academy students and alumni the option to attend the six-week Course “Leadership in Medical Affairs.” This specialized leadership course will combine theoretical leadership principles, with relevance in Medical Affairs, and practical applications. Students will have the opportunity to learn from industry leaders while participating in business case discussions, lectures, webinars, forums, and panel discussions, entirely online.

IFAPP Academy President/CEO, Module Chair

This new Course will help in leveraging leaderships skills to provide strategic medical direction to the organization” said Honorio Silva, MD, IFAPP Academy Chief Executive Officer, “and enhance the stakeholders perception of the medical function as a key contributor to improving patient outcomes.

Benefits for Medical Affairs Professionals

There are also numerous benefits of this collaboration for Medical Affairs professionals. Individuals will be taught the steps needed to evolve from leading themselves to achieving results through others. They will gain the understanding needed to transition from a medical/science contributor to a company leader. The course will provide professionals with the principles needed for creating and leading highly effective teams; including specialized teams (matrixed, cross-functional, cross-geographies). Students will understand how to provide value to an organization by translating real-world data, clinical outcomes, and other data insights into innovative solutions for patient needs and pharmaceutical challenges to allow for improved business development.

IFAPP Academy Advisory Council member, Ken Kaitin

Tufts CSDD is excited to partner with IFAPP Academy in offering this new online course on Leadership in Medical Affairs,” said Dr. Kenneth Kaitin, Professor and Director of Tufts CSDD. “The program will be a fitting compliment to Tufts CSDD’s annual two day in-person course on Leadership for Drug Development Teams, now in its 18th year. Additionally, I look forward to serving on the IFAPP Academy’s Advisory Council and working with the organization’s staff as we develop this exciting new online program.”

Tufts CSDD partners with IFAPP Academy for Leadership in Medical Affairs

About Tufts Center for the Study of Drug Development (Tufts CSDD) at Tufts University

The Tufts Center for the Study of Drug Development (http://csdd.tufts.edu) at Tufts University provides data-driven analysis and strategic insight to help drug developers, regulators, and policy makers improve the efficiency and productivity of pharmaceutical R&D. Tufts CSDD also offers professional development courses, hosts workshops and public forums, and publishes the Tufts CSDD Impact Report, a bi-monthly newsletter focusing on critical drug development issues.

IFAPP Academy online medical affairs course

About IFAPP Academy

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy (https://ifappacademy.org/) is a non-profit organization based in the USA, affiliated with IFAPP, and is comprised of a unique partnership between academia, industry, and professional associations to foster competencies and improving performance in medical affairs and medicines development. The IFAPP Academy-Kings College London, Medical Affairs in Medicines Development, Certification Program was created to achieve this goal. The online Program aims to provide the core cognitive competencies for an effective performance in medicines development and medical affairs. The certification program is of particular value for those individuals already working in (or interested in joining) pharmaceuticals, academia, and regulatory agencies. Students successfully completing the course receive a Certificate granted by King’s College London and IFAPP Academy, a Professional Certification granted by IFAPP and the IFAPP Academy, and the use of post-nominal letters (CMD) to attest certification.

Frequently Asked Questions

Learn more about the IFAPP Academy/King’s College London, Medical Affairs in Medicines development, Certification Program

Presented by Dr. Gustavo Kesselring

Want to learn how to expand your skill set and continue your professional development in Medical Affairs?

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy provides online Continuing Professional Development for Medical Affairs Professionals.

The IFAPP Academy is a non-profit organization whose mission is to promote, develop, and implement educational activities that support Pharmaceutical Medicine by enhancing the knowledge, expertise, and skills of pharmaceutical physicians and medicines development scientists worldwide. Partnered with King’s College London, the Academy offers Professional Certification for students successfully completing the course. Click here to learn more about the benefits of Professional Certification from the IFAPP Academy.

Get to know IFAPP Academy Student, Dr. Epaïnète GAWA

IFAPP Academy Student Dr. Epaïnète GAWA, Global Medical Expert, Sanofi
  • What is your name and job title?

Epaïnète GAWA, Global Medical Expert in Sanofi Consumer Healthcare

  • What do you feel is your greatest achievement?

My professional development in recent years. It’s a real opportunity to be part of the global medical team of Sanofi consumer healthcare. Indeed I have joined Sanofi at the local level by working on transversal projects, medico-marketing, pharmacovigilance, and clinical studies.
Today I have a specific medical position, with close interaction with regulatory and pharmacovigilance teams. As a partner, I give my best, and I also learn from others to face future challenges.

  • What is your favorite hobby and/or activity outside of your work?

 Football, scrabble, cinema, reading

  • What do you enjoy most about being a Medical Affairs Professional?

As a physician, my greatest satisfaction is to contribute to the well-being of the patient through an assessment of products based on their efficacy and safety datas, and to propose a risk mitigation plan. In addition i like the medical strategy because it helps to identify the real needs of patients and to propose the appropriate actions.

  • What has been the most beneficial aspect of the IFAPP Academy Program?

This program gives a broader view of the medical affairs function, and the skills required. The role of the medical affairs professional is well highlighted in all activities of the pharmaceutical industry, and this helps to better understand how we can be a key partner of other functions.

  • How has your view of the medical affairs profession altered and/or improved?

I limited the medical affairs to my personal experience but this program has shown me the evolution of the profession and the added value of our role in the life of the drug. Some topics that were abstract are now concrete for me. It is a specialty that deserves to be recognized in view of the complexity of the various skills required to be a professional in medical affairs. This profession has a major role in all decisions concerning the life of the product, from the discovery of the molecule to the monitoring and innovation of the mature product. The professionals must be multi-skilled and have a critical judgment in all discussions hence the extensive knowledge provided by this program.

  • Any additional comments that you would like to make about the Program?

This program is an opportunity to exchange with experts and other professionals from the pharmaceutical industry through webinars and forums. In addition to deepening our knowledge, it is a professional network that is created.

Thanks to Sanofi which is a partner of this program, and thanks to the IFAPP team for your expertise.

The IFAPP Academy welcomes Ana B. Salgado as the new Director of Strategic Planning

Ana B has extensive professional experience in Medical Affairs, Marketing, and senior Business Management. We look forward to her contributions to the sustained growth of the Academy and achieving our mission and goals.

Ana B. Salgado, IFAPP Academy Director of Strategic Planning

Dr. Ana B. Salgado is a highly motivated and energetic pharmaceutical business executive with extensive global experience.

A physician by training, after three years of practicing medicine in the emergency room setting, Dr. Salgado started her pharmaceutical career as Medical Affairs Manager in Roche- Colombia. Her high affinity for change and continuous learning took her career into marketing and the commercial business. She joined Pfizer, where she occupied positions of increasing responsibility in marketing at a country level (Colombia) and later, at regional (Latin America, Europe) and global levels. She worked on products and portfolios across several therapeutic categories including anti-infectives, anti-inflammatories, and neuroscience in collaboration with multi-disciplinary teams around the world. Dr. Salgado was responsible for the launch of Celebrex in Latin America, several neuroscience launches in Europe (Zeldox, Relpax, Lyrica) and she led the Global Team for Aricept (in an alliance collaboration with Eisai – Japan).

Expanding her knowledge into the commercial business, Dr. Salgado served in business operations roles at regional and global level. She became the Chief of Staff for the Established Products/ Emerging Markets Business Unit at Pfizer, a business unit with a $25B yearly turnover. In these roles, Dr. Salgado led and participated in several large and complex corporate initiatives including the mergers of Pfizer with Warner Lambert, Pharmacia and Wyeth; several company reorganizations and the creation of the Established Products Business Unit. Before leaving Pfizer, Dr. Salgado led a global transformation to a customer centric – digitally enabled marketing model.

Dr. Salgado received her medical degree from Pontificia Universidad Javeriana in Colombia. She is currently pursuing a Certificate in Financial Planning.

IFAPP Academy 2019 Cohort Excelling!

The 2019 Cohort has just completed the first of six Modules required to earn their Medical Affairs in Medicines Development Certification (CMD). In the past month students have learned about the purpose and identity of medical affairs, received an introduction to pharmacology, overviewed the clinical trial process, networked with their fellow students during webinars and lesson discussions, and much more!

We are proud to announce that we have a few students who received perfect scores for their work in Module 1! This means they attended all lectures, webinars, and achieved full marks in participation for each activity. This is by no means a small feat. Their dedication to the Program has not only exceeded expectations through their academic achievements but also through their interactions with their fellow students.

We look forward to sharing with you the continued success of each one of the students in this Cohort.

Want to learn more about the IFAPP/King’s College London, Medical Affairs in Medicines Development, Certification Program?

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy provides online Continuing Professional Development for Medical Affairs Professionals.

The IFAPP Academy is a non-profit organization whose mission is to promote, develop, and implement educational activities that support Pharmaceutical Medicine by enhancing the knowledge, expertise, and skills of pharmaceutical physicians and medicines development scientists worldwide. Partnered with King’s College London, the Academy offers Professional Certification for students successfully completing the course. Click here to learn more about the benefits of Professional Certification from the IFAPP Academy.

IFAPP Academy Meeting in Budapest

Budapest 2018

In November 2018, the IFAPP Academy was invited by Sandor Kerpel-Fronius to hold the annual face-to-face Steering Committee meeting at the prestigious Semmelweis University in Budapest, Hungary.

Just a few of the Academy’s Board members and operational team

The IFAPP Academy Board Members, stakeholders, IFAPP’s secretariats, and the operations team gathered the first evening in Budapest to share a light dinner, a couple of drinks, and some good conversation.  

The first morning of meetings kicked off with Professor Sandor Kerpel-Fronius, faculty at the Semmelweis University, giving us a history of the University, insider tips to the city, and an overview of the meeting agenda. 

Professor Sandor Kerpel-Fronius inviting us inside the Semmelweis University for our first meeting.

The Academy was excited to welcome Tim Aldwinckle, UCB representative, to the meeting. He was able to provide some great perspective in several areas of the discussion.

After a full day of presentations, the team enjoyed an amazing dinner at Budapest’s Museum Restaurant.

The IFAPP Academy meeting attendees gather for dinner at the Museum Restaurant

Day 2 of the meeting – Gustavo Kesselring and Xavier Luria discussed the strategic collaborations that the IFAPP Academy will be fostering in 2019. Peter Stonier also presented the updated contract with King’s College London. The afternoon was concluded with coffee and the recording of video testimonials starring some of the key representatives of the Academy.

It was a great few days in Budapest and wonderful for the team to be able to spend some quality time together and workout the logistics for a successful 2019 and beyond!

Check out some more of the pictures from the Budapest Steering Committee Meeting:

ICPM 2018 presents the IFAPP Academy, Medical Affairs in Medicines Development, Program Graduates

News from IFAPP Academy

ICPM 2018 presents IFAPP Academy Graduates

What is ICPM?

The International Conference of Pharmaceutical Medicine (ICPM) is the largest event for the International Federation of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP).

ICPM is held every two or three years and is aimed to provide state of the art information in key areas for our discipline and profession. ICPM 2018 was held in Tokyo, September 27th – 29th, (www.icpm2018tokyo.com) in collaboration with the Japanese Association of Pharmaceutical Medicine (http://www.japhmed.org) and brought together around 400 representatives from the pharmaceutical, clinical research, and regulatory arenas from all over the world.


Gustavo Kesselring, MD International Affairs, IFAPP

“Attending the International Conference of Pharmaceutical Medicine (ICPM) is an outstanding opportunity to learn about the news trends in pharmaceutical medicine and medicines development, besides networking with world class faculty from academia, pharmaceutical companies, and government officials in a friendly environment.

Since 2006, in Seoul, I have attended all ICPMs. Being in Tokyo this year, attending the latest ICPM, I am still thrilled about how Pharmaceutical Medicine can motivate people from all parts of the world to get together and discuss the Future of Medicines Development. Hope you don´t miss the ICPMs in the coming years.”


Dr. Marcos O. Perez III receiving his CMD Certificate

Dr. Marcos O. Perez III receiving his CMD Certificate

From left to right: Drs. Gustavo Kesselring, Warachal Eileen Faison (with CMD Certificate), and Honorio Silva

From left to right: Drs. Gustavo Kesselring, Warachal Eileen Faison (with CMD Certificate), and Honorio Silva

Dr. Honorio Silva Introduces the Graduates from the IFAPP Academy Program

Students graduating from the Program were invited to attend ICPM 2018 in Tokyo. Although not all of the students were able to make the trip for the ceremony, Dr Honorio Silva honored each of them through a presentation that included their pictures, job titles, and affiliations.

The students that were able to attend the ceremony were provided free admittance into the conference and presented with their Certificate in Medicines Development (CMD) during the awards ceremony, held the first day of the conference.

Want to learn more about the IFAPP Academy?

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy provides online Continuing Professional Development for Medical Affairs Professionals.

The IFAPP Academy is a non-profit organization whose mission is to promote, develop, and implement educational activities that support Pharmaceutical Medicine by enhancing the knowledge, expertise, and skills of pharmaceutical physicians and medicines development scientists worldwide. Partnered with King’s College London, the Academy offers Professional Certification for students successfully completing the course.

Click here for more information! Applications are now being accepted for the 2019 Cohort. Application deadline is Dec. 1st, 2018